Breaking
Friday, June 19, 2026

Lung Cancer News

🇺🇸 FDA

FDA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–11 of 11 articles

High impact NewsJun 8, 2026

Arcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab

kidney cancer · 4 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

China’s Rise in Drug Development Looms Over U.S. Oncology Market

FDA · oncology · 5 min

Dr. Sarah Mitchell
Medium impact NewsMay 31, 2026

China Approves HERNEXEOS for Lung Cancer Treatment

China · oncology · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 17, 2026

Amgen Inc Stock: Lung Cancer Setback Meets Steady Cash Flow

lung cancer · 3 min

Dr. Sarah Mitchell
Critical impact NewsMay 1, 2026

Summit Therapeutics Ivonescimab Shows Overall Survival Benefit in Lung Cancer, ASCO 2026 Plenary Data Expected

Non-Small Cell Lung Cancer (NSCLC) · 3 min

Dr. Priya Nandakumar
Critical impact NewsApr 29, 2026

ASCO 2026: Top Oncology Trials to Watch

oncology · 5 min

Dr. Sarah Mitchell
High impact NewsApr 22, 2026

Pfizer Presents LORBRENA and BRAFTOVI Cancer Trial Updates at ASCO 2026

2 min

Michael Rivera
High impact NewsApr 20, 2026

Revolution Medicines Presents Updated Zoldonrasib Phase 1 Data for KRAS G12D Lung Cancer at AACR 2026

2 min

James Chen, PharmD
High impact NewsApr 17, 2026

Boehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study

Non-small cell lung cancer (NSCLC) · 3 min

James Chen, PharmD
High impact NewsApr 9, 2026

FDA Approves Tecentriq for Extensive-Stage Small Cell Lung Cancer

FDA · oncology · 4 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC

FDA · non-small cell lung cancer · 4 min

Dr. Sarah Mitchell